Light you can't see, reaching tissue nothing else can.
Near-infrared light therapy — photobiomodulation — uses wavelengths in the 600–1100nm band to drive cellular energy production at the mitochondria. Consumer panels run low irradiance and stop at the skin. Clinical-grade devices push enough power through to reach the tissue underneath: muscle, joint, bone, and brain.
Deep-tissue NIR at 820nm, 850+ mW/cm² — the wavelength sits squarely on the absorption peak of cytochrome c oxidase, the enzyme inside your mitochondria that turns the light into ATP. The irradiance is high enough to penetrate roughly 5cm into tissue, reaching muscle, joint, and bone that surface-level panels can't touch. Transcranial work uses 810nm — the most-studied wavelength for brain applications.
People with localized inflammation, joint or musculoskeletal pain, soft-tissue injury or post-training recovery, and — with transcranial 810nm — neurological work including TBI, depression, and cognitive performance. The full list is on the treatment and performance pages.
Six photobiomodulation mechanisms with published evidence — from mitochondrial ATP enhancement to neuroplasticity. Wavelength penetration, dose-response curves, and transcranial applications.
Example courses for different target tissues — neuro, musculoskeletal, systemic. What a real course looks like and where it bends to your situation.
Your first session, what the light feels like on skin, eye protection, and what changes over a course.
How to find us, what to bring, the property, and how a visit unfolds.
Often paired with hyperbaric oxygen therapy — different physics, converging biology.